drugset
drugset / Trial / NCT03642262

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

NCT03642262 ↗

Phase 1 Completed 30 enrolled Reckitt Benckiser Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

Demonstrate bioequivalence of guaifenesin in Mucinex® extended release (ER) 600 mg tablet in normal healthy volunteers compared to the immediate release guaifenesin 200 mg tablet reference product marketed

Timeline

Start
2013-06-02
Primary completion
2013-08-09
Completion
2013-08-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 200 mg Oral
Subject Guaifenesin Small molecule 600 mg Oral

Indications

No indication recorded.